To compare the performance of the Eleveld models for propofol and remifentanil on neurosurgery patients admitted to intensive care with their intraoperative performance.
Despite the widespread adoption of Target Controlled Infusion (TCI) models in modern clinical anesthesia practice, much less attention has been paid in the literature to their potential applications in the Intensive Care Unit (ICU) setting. Few studies have been published so far to evaluate the performance of TCI pumps for sedatives and other drugs (e.g., antibiotics) in Intensive Care. Further data is needed regarding the use of TCI for the long-term infusion of these drugs in the ICU after surgery, and the quantitative relationship between generalized pharmacokinetic/pharmacodynamic models for propofol and remifentanil (the Eleveld models) has yet to be evaluated in this specific population. This study is an observational study with the aim of clarifying the predictive performance of the TCI models for the administration of propofol and remifentanil in a cohort of intensive care patients admitted after neurosurgery and compare it to the intraoperative performance, which can be taken as benchmark.
Study Type
OBSERVATIONAL
Enrollment
42
Foundation IRCCS Carlo Besta Neurological Institute
Milan, Italy, Italy
RECRUITINGFondazione IRCCS Istituto Neurologico C. Besta
Milan, Milano, Italy
RECRUITINGMdAPE difference for propofol
The difference in MdAPE will be measured when comparing the model performance for propofol in the ICU to the intraoperative phase.
Time frame: october 2024
MdAPE difference for remifentanil
The difference in MdAPE will be measured when comparing the model performance for remifentanil in the ICU to the intraoperative phase.
Time frame: october 2024
Propofol and remifentanil metabolites
Metabolites of propofol and remifentanil (4-hydroxy propofol and remifentanil acid) during infusion
Time frame: october 2024
BIS profile
Bispectral index monitor profile during infusion (min = 0, max = 100)
Time frame: october 2024
NOL profile
NOL (Nociceptive Level) value (min = 0, max = 100)
Time frame: Oct 2024
RASS
RASS measurements during infusion (min = -5, max = +4).
Time frame: october 2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.